Spinal Cord Stimulation for Therapy-Resistant Neuropathic Pain After Lumbar Spinal Surgery A Randomized, Double-Blind, Sham-Controlled, Cross-over Study
Led by Sahlgrenska University Hospital · Updated on 2025-12-02
50
Participants Needed
4
Research Sites
N/A
Total Duration
On this page
AI-Summary
Brief Title
Who Can Participate
AI-Screening
Your Study Journey
Trial Site Locations
Research Team
How is the study designed?
Similar Trials
Frequently Asked Questions
Research Publications
Sponsors
S
Sahlgrenska University Hospital
Lead Sponsor
R
Rijnstate Hospital
Collaborating Sponsor
AI-Summary
What this Trial Is About
Researchers are evaluating spinal cord stimulation (SCS) as a treatment for persistent neuropathic leg pain that continues after lumbar spinal surgery and does not improve with medication or other conservative treatments. This study is a multicenter, double-blind, randomized, sham-controlled trial designed to compare the long-term effects of active, subthreshold SCS versus no stimulation (placebo) on reducing neuropathic leg pain in patients with persistent spinal pain syndrome type 2 (PSPS2). The study aims to assess not only pain reduction but also quality of life, physical functioning, sleep quality, return to work, and medication use.
Participants who respond positively to a two-week SCS test trial will have a non-rechargeable Boston Alpha Prime SCS system implanted. After initial electrode implantation and a trial phase, those with adequate pain relief will receive a permanent implant. The study includes a four-week optimization period followed by a six-month randomized crossover phase where patients receive either active subthreshold stimulation or sham stimulation for three months each. Then, participants will use their preferred stimulation form for an additional six months. Both patients and physicians remain unaware of the stimulation status during the blinded phases, with only a research nurse managing programming.
During the study, participants will complete questionnaires before implantation and at regular follow-ups at 3, 6, and 12 months. Researchers will monitor changes in leg pain intensity using the Numeric Rating Scale (NRS) and evaluate secondary outcomes such as quality of life and physical function. After completing the 12-month follow-up, blinding will be lifted, and participants may choose any available stimulation form. The total participation duration is approximately one year, including surgery, stimulation phases, and follow-up assessments.
CONDITIONS
Brief Title
Placebo Effect In Spinal Cord Electrical Stimulation for Pain
Who Can Participate
Age: 18Years - 70Years
All Genders
Eligibility Criteria
You may qualify if you...
History consistent with persistent spinal pain syndrome type 2 (PSPS2) lasting at least 6 months after last spinal surgery
Patients aged between 18 and 70 years
Average leg pain intensity of 5 or more and back pain less than 3 on the Numeric Rating Scale (0-10)
Provided informed written consent after verbal and written study information
Achieved at least 50% pain relief during a 2-week active spinal cord stimulation test trial
You will not qualify if you...
Unable to understand or operate the spinal cord stimulation device
Currently have an active implantable device such as pacemaker or intrathecal drug delivery system
Have an ongoing coagulation disorder
Abuse of alcohol, drugs, or prescription opioids
Active debilitating psychiatric illness
Active malignancy
Condition causing increased infection risk, such as immunodeficiency
Expected lifespan less than 1 year
Ongoing local infection or skin disease where the implantable pulse generator is planned
Pregnancy
AI-Screening
AI-Powered Screening
Complete this quick 3-step screening to check your eligibility
1
2
3
Your Study Journey
Screening
Duration - 2 to 4 weeks
Participants are screened for eligibility to participate in the trial.
1 screening and enrollment visit
Surgery
Duration - Initial surgery and recovery period
Participants undergo surgery to implant electrode(s) into the epidural space for spinal cord stimulation.
1 surgical visit plus recovery period
Run-in Period
Duration - 2 weeks
Participants undergo a 2-week trial phase with external stimulation to determine if adequate pain relief is achieved.
Trial phase with external device; visits not specifically detailed
Surgery
Duration - Permanent implant surgery and recovery
Participants who respond positively to the trial phase receive implantation of a permanent pulse generator under the skin.
1 surgical visit plus recovery period
Treatment
Duration - 12 months
Participants receive either active subthreshold spinal cord stimulation or sham stimulation in a double-blind, randomized crossover design with a 4-week optimization period followed by two 3-month stimulation periods and a final 6-month period using the preferred stimulation.
Routine follow-up visits at 3, 6, and 12 months
Trial Site Locations
Total: 4 locations
1
Department of Anaesthesiology and Pain Management, Rijnstate Hospital
Arnhem, Netherlands, 6800
Actively Recruiting
2
Department of Neurosurgery, Stavanger University hospital
Stavanger, Norway, 4019
Actively Recruiting
3
Department of Neurosurgery, Sahlgrenska University Hospital
Gothenburg, Sweden, 41257
Actively Recruiting
4
Department of Anesthesiology and Intensive Care/Pain Center, Sahlgrenska University Hospital Östra
The appropriate use of neurostimulation of the spinal cord and peripheral nervous system for the treatment of chronic pain and ischemic diseases: the Neuromodulation Appropriateness Consensus Committee.
The incidence and healthcare costs of persistent postoperative pain following lumbar spine surgery in the UK: a cohort study using the Clinical Practice Research Datalink (CPRD) and Hospital Episode Statistics (HES).
Novel 10-kHz High-frequency Therapy (HF10 Therapy) Is Superior to Traditional Low-frequency Spinal Cord Stimulation for the Treatment of Chronic Back and Leg Pain: The SENZA-RCT Randomized Controlled Trial.
Spinal Cord Stimulation (SCS) with Anatomically Guided (3D) Neural Targeting Shows Superior Chronic Axial Low Back Pain Relief Compared to Traditional SCS-LUMINA Study.